Spending money to make change: Association of methamphetamine abstinence and voucher spending among contingency management pilot participants in South Africa.

Behavioral economics Contingency management Cross-cultural replication Methamphetamine use disorder South Africa

Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
05 2020
Historique:
received: 27 09 2019
revised: 22 01 2020
accepted: 24 01 2020
entrez: 23 3 2020
pubmed: 23 3 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Methamphetamine Use Disorder is prevalent in South Africa. This analysis uses data from a contingency management (CM) pilot study in South Africa to replicate and expand on a U.S.-based study showing that CM voucher spending was associated with drug abstinence behavior. Participants with methamphetamine-use disorder were enrolled in an 8-week CM trial requiring thrice weekly visits and received cash vouchers in exchange for stimulant-negative urines at each visit. Participants were 33 treatment-seeking individuals with methamphetamine use disorder including 22 men (66.7%) and 11 women (33.3%) with a mean age of 34 years (S.D. = 7.7). Participants reported using methamphetamine for a mean of 11.7 years (S.D. = 4.9). All study procedures took place in South Africa between August 2016 and May 2018. A time-lagged counting process Cox Proportional Hazards model for recurrent event survival analysis examined the relationship between frequency of and participant-categorized type of CM expenditures (hedonic, utilitarian, consumable or durable) and drug abstinence. After controlling for severity of baseline methamphetamine use and accumulated CM earnings (proxied by cumulative negative urines), those spending CM earnings at a previous visit ("spenders") were more likely to produce stimulant-negative urine samples subsequently, compared to those who did not ("savers") [OR = 1.23, CI = 1.08-1.53, p = .002]. There were significantly more cumulative stimulant-negative results among spenders vs. savers, p < .001, although cumulative spending did not significantly predict abstinence once spending in the prior time period was controlled for, suggesting a recency effect tied to the underlying spending mechanism. When extending the original analyses to look at the effect of spending on current abstinence, controlling only for recent abstinence (rather than cumulative abstinence), spending was no longer a significant predictor. Spending type did not affect methamphetamine abstinence. Qualitative results suggest spending CM vouchers may support social reintegration over the course of the trial. Abstinence outcomes are a function of CM spending in both the U.S. and South Africa. Findings of a significant relationship between contingency management spending and subsequent stimulant-negative urine samples across geographic locations provide guidance toward future work in optimizing CM efficacy.

Identifiants

pubmed: 32199547
pii: S0740-5472(19)30528-8
doi: 10.1016/j.jsat.2020.01.014
pmc: PMC7089867
mid: NIHMS1568183
pii:
doi:

Substances chimiques

Methamphetamine 44RAL3456C

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-67

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001856
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA040492
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there are no competing interests.

Références

Psychol Sci. 2007 Jan;18(1):58-63
pubmed: 17362379
Drug Alcohol Rev. 2008 May;27(3):253-62
pubmed: 18368606
Health Econ. 2017 Nov;26(11):1394-1411
pubmed: 27671119
Subst Use Misuse. 2010 Nov;45(13):2221-43
pubmed: 21039113
Psychiatry J. 2014;2014:929767
pubmed: 24829904
Addiction. 2010 Jun;105(6):991-1002
pubmed: 20659059
J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S124-9
pubmed: 27355499
PLoS One. 2018 Jun 14;13(6):e0196616
pubmed: 29902177
J Subst Abuse Treat. 2014 Jul;47(1):73-7
pubmed: 24674235
Drug Alcohol Rev. 2016 Sep;35(5):580-3
pubmed: 26661781
AIDS. 2017 Mar 27;31(6):815-825
pubmed: 28107221
Addiction. 2006 Feb;101(2):267-74
pubmed: 16445555
Drug Alcohol Rev. 2008 Mar;27(2):185-9
pubmed: 18264880
J Subst Abuse Treat. 2019 May;100:64-83
pubmed: 30898330
Drug Alcohol Rev. 2020 Mar;39(3):216-222
pubmed: 31863530
Psychother Res. 2015;25(4):435-44
pubmed: 24708408
Afr J Psychiatry (Johannesbg). 2011 Nov;14(5):372-6
pubmed: 22183467
Soc Sci Med. 2008 Aug;67(4):618-27
pubmed: 18538457
Drug Alcohol Depend. 2007 Dec 1;91(2-3):293-6
pubmed: 17720334
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Drug Alcohol Depend. 2012 Apr 1;122(1-2):86-92
pubmed: 21981991
Lancet HIV. 2016 Feb;3(2):e85-93
pubmed: 26847230
Drug Alcohol Depend. 2005 May 9;78(2):125-34
pubmed: 15845315
BMC Public Health. 2010 Dec 20;10:774
pubmed: 21172026
Psychol Addict Behav. 2016 Aug;30(5):536-543
pubmed: 27442691
Subst Abuse Treat Prev Policy. 2015 Nov 14;10:46
pubmed: 26576946
Lancet Glob Health. 2017 Sep;5(9):e907-e915
pubmed: 28807189
Am J Drug Alcohol Abuse. 2010 Jul;36(4):208-13
pubmed: 20560840
Lancet HIV. 2018 Feb;5(2):e79-e86
pubmed: 29170030
J Exp Anal Behav. 1993 Jul;60(1):141-158
pubmed: 16812696
Addiction. 2011 Oct;106(10):1801-9
pubmed: 21793958
Metab Brain Dis. 2014 Jun;29(2):351-7
pubmed: 24532047
Addiction. 2007 Aug;102(8):1204-11
pubmed: 17565561
AIDS. 2017 Mar 13;31(5):719-726
pubmed: 28225450
Health Psychol. 2013 Sep;32(9):958-66
pubmed: 24001246
PLoS One. 2017 Feb 9;12(2):e0170686
pubmed: 28182706
Exp Clin Psychopharmacol. 2009 Jun;17(3):131-8
pubmed: 19586227
Drug Alcohol Depend. 2012 Nov 1;126(1-2):232-9
pubmed: 22717338
Annu Rev Psychol. 2008;59:29-53
pubmed: 18154498

Auteurs

Tamar Krishnamurti (T)

Division of General Internal Medicine, University of Pittsburgh, Meyran Avenue, Suite 200, Pittsburgh, PA 15213, USA. Electronic address: tamark@pitt.edu.

Kimberly Ling Murtaugh (K)

Department of Public Policy, Luskin School of Public Affairs, University of California at Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

Lara Van Nunen (L)

Department of Psychiatry and Mental Health, University of Cape Town, South Africa.

Alexander L Davis (AL)

Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, PA, USA.

Jonathan Ipser (J)

Department of Psychiatry and Mental Health, University of Cape Town, South Africa.

Steven Shoptaw (S)

Department of Public Policy, Luskin School of Public Affairs, University of California at Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA; Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH